Corvus Pharmaceuticals CRVS
NASDAQ CRVS
$14.39 -0.26 (-1.77%)
As of: Sep 4, 2026 · 3:59 PM EDT

Corvus Pharmaceuticals (CRVS) Change in Receivables (2025 - 2026)

Corvus Pharmaceuticals (CRVS) posted quarterly Change in Receivables of $6000.0 for Q1 2026, up 50.0% year-over-year from $4000.0 in Q1 2025, and up 50.0% quarter-over-quarter from $4000.0 in Q1 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Corvus Pharmaceuticals (CRVS) Change in Receivables (2025 - 2026) Analysis & Trends

Corvus Pharmaceuticals' Change in Receivables history runs 2 years deep, the most recent figure standing at $6000.0 for Q1 2026.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -53.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 117.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 31.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 37.16 Mn
10 Corvus Pharmaceuticals 1.33 Bn 1.12 Bn - -37,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37,000.00
Mar 31, 2026 6,000.00
Jun 30, 2025 7,000.00
Mar 31, 2025 4,000.00